Ernest T. Hawk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ernest T. Hawk has a total of 285 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Vilar
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, USA
21 shared publications - Patrick M. Lynch
University of Texas M. D. Anderson Cancer, Center
19 shared publications - Yisheng Li
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
19 shared publications - Alexander Joseph Lazar
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
18 shared publications - Christina M. Dieli-Conwright
Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
18 shared publications - Eunice Murage
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas
18 shared publications
Latest Publications
- 14 October 2026
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- p. OF1-OF6
Developing Effective, Evidence-Based Training for Cancer Team Science Leadership for National Impact
A 2025 National Academies’ report, The Science and Practice of Team Science, identified critical gaps in leadership development and highlighted evidence-based best practices and infrastructure needs to enhance team science. This brief perspective addresses team science approaches needed to overcome the complexities of cancer biology, carcinogenesis, and the processes for advancing cancer knowledge and clinical practice to effectively develop novel interventions. To define evidence-based leadership education programs rooted in the National Academies’ report and tailored for cancer researchers, we conducted a survey-based educational needs assessment and performed a structured literature review using Medical Subject Headings (MeSH) terms for cancer and team science. The review identified 53 articles with few focused on team science leadership and none on team science leadership training for cancer research. Survey responses from 58 national cancer research leaders involved in National Cancer Institute (NCI) P30 Cancer Center Support Grant (CCSG; n = 45), P01 (n = 18), U54 (n = 18), and P50 Specialized Program of Research Excellence (SPORE; n = 16) programs identified key skills for successful team science leadership: team leadership, strategic planning, grant planning/writing, translational/clinical leadership, science communication, mentorship, and conflict resolution. Cancer research leaders identified the biggest gaps in current training as team leadership, conflict resolution, team evaluation/metrics, systems thinking and analysis, and institutional navigation. From 68 midcareer faculty representing the audience for training, self-assessments revealed developing/managing large research grants, managing shared resources, and interdependencies as the most desired topics for training, with most preferring in-person training. Delivering structured training in the competencies of team science will better prepare established, independent investigators to lead larger, complex, multicomponent cancer research programs.
- 14 October 2026
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- p. OF1-OF6
Developing Effective, Evidence-Based Training for Cancer Team Science Leadership for National Impact
A 2025 National Academies’ report, The Science and Practice of Team Science, identified critical gaps in leadership development and highlighted evidence-based best practices and infrastructure needs to enhance team science. This brief perspective addresses team science approaches needed to overcome the complexities of cancer biology, carcinogenesis, and the processes for advancing cancer knowledge and clinical practice to effectively develop novel interventions. To define evidence-based leadership education programs rooted in the National Academies’ report and tailored for cancer researchers, we conducted a survey-based educational needs assessment and performed a structured literature review using Medical Subject Headings (MeSH) terms for cancer and team science. The review identified 53 articles with few focused on team science leadership and none on team science leadership training for cancer research. Survey responses from 58 national cancer research leaders involved in National Cancer Institute (NCI) P30 Cancer Center Support Grant (CCSG; n = 45), P01 (n = 18), U54 (n = 18), and P50 Specialized Program of Research Excellence (SPORE; n = 16) programs identified key skills for successful team science leadership: team leadership, strategic planning, grant planning/writing, translational/clinical leadership, science communication, mentorship, and conflict resolution. Cancer research leaders identified the biggest gaps in current training as team leadership, conflict resolution, team evaluation/metrics, systems thinking and analysis, and institutional navigation. From 68 midcareer faculty representing the audience for training, self-assessments revealed developing/managing large research grants, managing shared resources, and interdependencies as the most desired topics for training, with most preferring in-person training. Delivering structured training in the competencies of team science will better prepare established, independent investigators to lead larger, complex, multicomponent cancer research programs.
- 3 August 2026
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 19 (8) , 435-441
Early Detection of Cancer in Medically Underserved Populations
Limited access to healthcare due to poverty, lack of insurance, and/or excessive distance from healthcare services has been highlighted as a significant contributor to poor outcomes related to cancer incidence and cancer-related morbidity, survival, and mortality. Moreover, America’s primary reliance on employer-based health insurance means that those living without employment or in poverty frequently cannot afford healthcare and therefore experience poorer health outcomes. Because cancer screening that allows for early cancer detection saves lives, it is imperative that research on how to improve and increase cancer-related screening and early detection services for the medically underserved be prioritized and acted upon by policymakers and others responsible for implementing scientific discoveries to improve cancer-related population health.
- 3 August 2026
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 19 (8) , 435-441
Early Detection of Cancer in Medically Underserved Populations
Limited access to healthcare due to poverty, lack of insurance, and/or excessive distance from healthcare services has been highlighted as a significant contributor to poor outcomes related to cancer incidence and cancer-related morbidity, survival, and mortality. Moreover, America’s primary reliance on employer-based health insurance means that those living without employment or in poverty frequently cannot afford healthcare and therefore experience poorer health outcomes. Because cancer screening that allows for early cancer detection saves lives, it is imperative that research on how to improve and increase cancer-related screening and early detection services for the medically underserved be prioritized and acted upon by policymakers and others responsible for implementing scientific discoveries to improve cancer-related population health.
- Open Access
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Data from NCI-Designated Cancer Centers’ Policies and Practices with regard to Alcohol and Cancer: A Call to Lead
Background:Alcohol, a known carcinogen since 1988, increases risk of cancers of the mouth, pharynx, larynx, esophagus, liver, breast, and colorectum. More than one half of US adults consume alcohol whereas about two thirds are unsure whether or unaware that alcohol intake is linked to cancer risk.Methods:Our objective was to survey awareness, beliefs, intentions, policies, practices, and goals/perceived responsibilities related to establishing/promoting actions to reduce alcohol-related cancer risks from leaders of 72 NCI-Designated Cancer Centers.Results:Sixty-one percent responded. Forty-three percent either believed in or were uncertain about alcohol’s purported health benefits. Nevertheless, 86% considered it part of their job to warn the public about alcohol’s carcinogenic effects. Fifty-two percent had at least one alcohol-related policy in place; among that subset, 83% had a policy related to alcohol service during on-site events; 87% had one about reimbursement of that alcohol service. Of concern, only 45% of survey respondents agreed that current literature with regard to alcohol-related cancer risk factors was sufficient to warrant a reconsideration of their alcohol-related policies/practices, and fewer than half have acted on those data.Conclusions:NCI-Designated Cancer Centers can implement policies and change practices now to reduce alcohol intake and the cancer deaths associated with its consumption.Impact:Cancer centers’ leadership in alcohol practices and policies may energize the public to be more thoughtful about their use of alcohol, resulting in long-term reductions in associated cancer risks.See related In the Spotlight, p. 190
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from NCI-Designated Cancer Centers’ Policies and Practices with regard to Alcohol and Cancer: A Call to Lead
Background:Alcohol, a known carcinogen since 1988, increases risk of cancers of the mouth, pharynx, larynx, esophagus, liver, breast, and colorectum. More than one half of US adults consume alcohol whereas about two thirds are unsure whether or unaware that alcohol intake is linked to cancer risk.Methods:Our objective was to survey awareness, beliefs, intentions, policies, practices, and goals/perceived responsibilities related to establishing/promoting actions to reduce alcohol-related cancer risks from leaders of 72 NCI-Designated Cancer Centers.Results:Sixty-one percent responded. Forty-three percent either believed in or were uncertain about alcohol’s purported health benefits. Nevertheless, 86% considered it part of their job to warn the public about alcohol’s carcinogenic effects. Fifty-two percent had at least one alcohol-related policy in place; among that subset, 83% had a policy related to alcohol service during on-site events; 87% had one about reimbursement of that alcohol service. Of concern, only 45% of survey respondents agreed that current literature with regard to alcohol-related cancer risk factors was sufficient to warrant a reconsideration of their alcohol-related policies/practices, and fewer than half have acted on those data.Conclusions:NCI-Designated Cancer Centers can implement policies and change practices now to reduce alcohol intake and the cancer deaths associated with its consumption.Impact:Cancer centers’ leadership in alcohol practices and policies may energize the public to be more thoughtful about their use of alcohol, resulting in long-term reductions in associated cancer risks.See related In the Spotlight, p. 190
- Open Access
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from NCI-Designated Cancer Centers’ Policies and Practices with regard to Alcohol and Cancer: A Call to Lead
Supplementary Table S1: Participants provided 33 responses to the open-ended survey question shown in the first column of this supplementary table. All responses are shown below.
- 3 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from NCI-Designated Cancer Centers’ Policies and Practices with regard to Alcohol and Cancer: A Call to Lead
Supplementary Table S1: Participants provided 33 responses to the open-ended survey question shown in the first column of this supplementary table. All responses are shown below.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Figure S3. (A) Average time that study participants wore the Fitbit throughout the study; (B) Resting heart rate in study participants at baseline; (C) Average total minutes of exercise at heart rate 70-85% of PHR; (D) Average total minutes of exercise at heart rate >85% of PHR. (***, P ≤0.001; ****, P≤0.0001).
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Figure S3. (A) Average time that study participants wore the Fitbit throughout the study; (B) Resting heart rate in study participants at baseline; (C) Average total minutes of exercise at heart rate 70-85% of PHR; (D) Average total minutes of exercise at heart rate >85% of PHR. (***, P ≤0.001; ****, P≤0.0001).
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Table S3. Number of patients experiencing adverse events. Only those toxicities experienced while on the trial are presented in the table. Toxicities during the pre-study stage of the trial, for example, that were present before participants begin intervention were not included. Should a patient experience an adverse event more than once, the patient is only counted once at the highest grade for that adverse event.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Table S3. Number of patients experiencing adverse events. Only those toxicities experienced while on the trial are presented in the table. Toxicities during the pre-study stage of the trial, for example, that were present before participants begin intervention were not included. Should a patient experience an adverse event more than once, the patient is only counted once at the highest grade for that adverse event.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Figure S2. CYCLE-P trial study visits and follow-up.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Figure S2. CYCLE-P trial study visits and follow-up.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Figure S8. (A) Volcano plot of statistically significant genes and fold-changes between the usual care and exercise groups in DSP assay. Top significantly differentially expressed genes are labeled; (B) The dot plot presents enriched GSEA HALLMARK pathways. The sizes of the dots represent the count of core enrichment (leading-edge) genes. The colors of the dots represent the BH-adjusted P-values. The order of HALLMARK gene sets is based on the gene ratio (number of significant genes associated with the HALLMARK gene sets / total number of significant genes; (C) Total CD8+ T cell density per mm2 (left) and epithelial (right) in colonic mucosa preand post- intervention from usual care (n=4) and exercise (n=4) participants; (D) Total CD57+ NK cell density per mm2 (left) and epithelial (right) in colonic mucosa pre- and post- intervention from usual care (n=4) and exercise (n=4) participants.
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Figure S8. (A) Volcano plot of statistically significant genes and fold-changes between the usual care and exercise groups in DSP assay. Top significantly differentially expressed genes are labeled; (B) The dot plot presents enriched GSEA HALLMARK pathways. The sizes of the dots represent the count of core enrichment (leading-edge) genes. The colors of the dots represent the BH-adjusted P-values. The order of HALLMARK gene sets is based on the gene ratio (number of significant genes associated with the HALLMARK gene sets / total number of significant genes; (C) Total CD8+ T cell density per mm2 (left) and epithelial (right) in colonic mucosa preand post- intervention from usual care (n=4) and exercise (n=4) participants; (D) Total CD57+ NK cell density per mm2 (left) and epithelial (right) in colonic mucosa pre- and post- intervention from usual care (n=4) and exercise (n=4) participants.
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Table S6. Gene set enrichment analysis using the KEGG pathways and Gene Ontology Biological Processes databases. Pathways statistically significant activated or suppressed after twelve months exercise are displayed (BH-adjusted P-value<0.05).
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Table S6. Gene set enrichment analysis using the KEGG pathways and Gene Ontology Biological Processes databases. Pathways statistically significant activated or suppressed after twelve months exercise are displayed (BH-adjusted P-value<0.05).
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Figure S4. Relative change in prostaglandin metabolite levels after twelve months follow-up in usual care and exercise groups (A-C, Wilcoxon signed-rank test; ns, P>0.05; *, P ≤0.05; **, P≤0.01).
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Figure S4. Relative change in prostaglandin metabolite levels after twelve months follow-up in usual care and exercise groups (A-C, Wilcoxon signed-rank test; ns, P>0.05; *, P ≤0.05; **, P≤0.01).